Toxicological
sciences in Switzerland Definition and scope
Toxicology is a multidisciplinary
area of science that investigates the harmful effects of exogenous
and endogenous factors on biological systems, with the objective
to protect organisms, animals, man and the environment. Toxicological
investigations provide a scientific basis for the understanding
and the assessment of toxic effects. In this way, they provide
relevant information for governmental agencies to establish
safety and exposure limits. Apart from securing public health
and the environment, toxicology becomes increasingly important
for the evaluation and selection of technologies. It is an
essential area for the assessment of benefits and risks of
new products emanating from biotechnology and bioengineering
on a rational and scientific basis. The awareness, the hopes
as well as the fears of the public depend to a large extent
on the expertise of toxicologists.
Switzerland is a world leader in the research and development of new drugs
and in the production of pharmaceuticals. It also plays an important role in
the area of fine chemicals. Of equal importance to the swiss economy is food
processing. To maintain the lead in these areas, Swiss industries need highly
qualified individuals in the chemical and biological sciences covering fundamental
and applied aspects, including toxicology Toxicologists up to the doctorate
level are essential for safety evaluation and risk assessment. For this reason,
the academic institutions must provide a curriculum towards the formation of
toxicologists.
Initiation of this report
The Swiss Institute of Toxicology in Schwerzenbach, an academic institution
jointly operated by the University of Zurich and the ETH has been the center
of toxicology for the last twenty years. It has conducted applied toxicological
research and has provided expertise and post-graduate education. However the
activities of this Institute have recently been found to be insufficiently
adapted to the rapid growth in knowledge in biological and medical research
and in technology, and it will cease its activities in the year 2001.
In light of this situation, the Swiss Society of Pharmacology and Toxicology
has undertaken a review of the actual state of toxicology in Switzerland. The
Swiss Academy of Sciences and the Swiss Academy of Medicine have supported
this study financially and the Swiss Science Council has been consulted on
several occasions.
In early 1998 a questionnaire was sent to 100 selected individuals actively
involved in toxicology and the 48 returned questionnaires were used as a basis
for the analysis given in this report. In addition, group hearings and meetings
with scientists were held in Basel, Geneva, Lausanne and Zurich. Concurrently,
the register of toxicologists in Switzerland, a Swiss continuing eduction program
(Nachdiplom) for professional toxicologists, a website of the section of toxicology
of SSPT, and the local Zurich "Center for Xenobiotic and Environmental Risk
Research" were created.
Results
The study reveals that over 900 persons are engaged in the various fields
of toxicology in Switzerland, 1/3 of them having an academic education and
2/3 a technical one. The main employers of toxicologists are in decreasing
order : industry, universities or Federal Institutes of Technologies (ETHZ/EPFL),
and governmental agencies. The current activities of toxicologists cover a
wide range of areas ranging from the basic sciences to occupational safety,
forensic toxicology and preventive medicine. With respect to academic research
and education, Zurich is the main center followed by Lausanne, Geneva, Basle,
and Berne. Industrial and food toxicology is concentrated within the multinational
companies in Basle and the Lausanne area, respectively. Public advice in acute
and chronic cases of poisoning and clinical toxicology services are provided
by the Swiss Toxicological Information Center (STIC) in Zurich (Schweizerisches
Toxikologisches Informationszentrum Zurich, STIZ). This center works closely
with the clinical departments of the University Hospital in Zurich.
Identified issues and weaknesses of this study are as follows:
the lack of coordination and communication within and among the different
centres became apparent from the majority of the questionnaires as well as
from the hearings. These centers, involved in toxicology oriented research,
were from academic, industrial, governmental and public sectors. The situation
will worsen with the closure of the Swiss Toxicology Institute in Schwerzenbach
in 2001
the lack of information flow from toxicologists to the general public was noted
the urgent need for more research, education and training in all fields of
toxicology was emphasized by toxicologists from industry, government, and academic
institutions
the potential lack of toxicological services and support in the near future
was expressed by specialists from governmental agencies
Recommendations
Based on this analysis, the following proposals are put forward to improve
basic and applied toxicological research and education in Switzerland:
RESEARCH
increased activity and support in the areas concerning biological and medical
effects caused by xenobiotics (basic toxicology and ecotoxicology)
increased activity and support for safety investigations regarding new technologies
on human health and the environment
coordination of multidisciplinary toxicological research activities throughout
Switzerland
strengthening collaborations between basic research and applied/issue-related
investigations
obtain additional resources for existing laboratories through the provision
of toxicological services
benchmarking with toxicological research activities in other countries
EDUCATION
coordination among the locally existing education centres to provide interdisciplinary
graduate and postgraduate courses, seminar series and continuing education
in all aspects of toxicology
collaboration with on-going toxicological education programs in Europe, US
and Japan
To translate the above proposals into action, we propose the creation of a
Swiss network (SWISSTOX) with the following objectives and mission.
Collaboration: To establish close interactions and collaborative projects among
the universities, the Swiss Federal Institutes of Technology, the industry
and the governmental agencies in all aspects of modern toxicological research.
Education: To provide adequate integrated training programs for toxicologists
and to implement a Ph.D. curriculum in toxicology.
Service function: To perform specific applied/issue-related toxicological investigations
and to provide timely toxicological data for governmental agencies and industry.
Public relations: To communicate new developments and toxicological concerns
to the public and to provide them with a brochure on Toxicology.
International relations: To expand links with toxicological centers and international
societies in other countries.
In order to implement these recommendations, a follow-up study group should
be formed. They will elaborate on a concise proposal regarding the structure,
financing, timeframe, and the mission of the proposed SWISSTOX network.
Foreword and Acknowledgements
Hardly a week goes by without news of a chemical that could potentially
threaten our health: pesticides or dioxin in food, pollutants in the air, chemicals
in the water, toxic dump sites near our homes. Are these chemicals really dangerous?
How much does it take to cause harm? What are the long term effects of chemicals
with regard to risks for cancer, the nervous system or birth defects?
Finding answers to these questions is what toxicologists do. Modern toxicology
has become multidisciplinary and is based in a variety of fields in science
and medicine. It deals with the effects of chemical and biological substances
on human and environmental health, defines potentially harmful interactions
between endogenous and exogenous risk factors and investigates toxicological
effects in experimental systems. In many cases toxicology is also involved
in the definition of regulatory standards and legislation designed to protect
human and animal health as well as the environment from deleterious damage
by potentially harmful agents.
In the biomedical area, pharmacologists and toxicologists investigate the mechanism
of action and effects of drugs. Toxicologists are concerned with the assessment
of the toxic risk of xenobiotic substances for human and animal health. Clinical
toxicologists are concerned with the pathogenesis, prevention, and treatment
of acute and chronic poisonings. They are also involved in the clinical testing
of specific antidotes and the elaboration of guidelines for the early detection
and therapy of xenobiotic injury in humans and animals.
Important new developments and specialized disciplines of toxicology include "Molecular
Toxicology" (e.g. toxicogenetics) and "Environmental Risk Assessment". These
areas span a wide range of methodology ranging from molecular biology (e.g.
molecular "biomarkers") to molecular and clinical epidemiology. In order to
master these multidisciplinary tasks, future toxicologists working in different
areas must closely collaborate and develop synergies and complementary functions
in the elucidation of the mechanistic basis of toxic effects, in the prevention
of chemical and environmental risks for public health and in the development
of adequate intervention strategies in case of major chemical accidents.
With the rapid global development and use of new technologies, toxicology,
in particular the domain of safety evaluation and risk assessment, will obtain
an ever increasing importance. It represents an important tool in the evaluation
and selection of new technologies leading to sustained economic development,
safety of public health and protection of the environment. In industry, toxicologists
significantly contribute to the safety of the products developed at companies
such as at Novartis, Roche, Nestlé, Clariant, Ciba-Specialty, and Ares-Serono.
Most of them were placed among the top companies in the Business Week Global
1000 list (see e.g. Business Week, pp. 49, July 13, 1998).
The Swiss Institute of Toxicology in Schwerzenbach, an academic institution
jointly operated by the University of Zurich and the ETH, has so far fulfilled
the role of a centre of education, research, risk assessment, information and
public service. As toxicology is rapidly becoming a multidisciplinary discipline
with exponential progress of knowledge in different subspecialities, revision
of the traditional "one-centre" concept of toxicology in Switzerland is necessary.
This concept has already been implemented on a local basis by the creation
of a multidisciplinary "Centre for Xenobiotic and Environmetal Risk Research
Zurich". This network serves as the nucleus for toxicological education, research
and services among 18 local institutes in the area of Zurich.
On a national basis the Swiss Society of Pharmacology and Toxicology (SSPT)
in collaboration with the Swiss Academy of Sciences and the Swiss Academy of
Medicine has initiated an analysis of the current status of toxicology in Switzerland.
A questionnaire was sent to more than 100 individuals actively involved in
toxicology in order to evaluate their activities during the past 5 five years,
their present situation and their prospects and needs for the next 5 years.
In addition, several hearings and meetings were held in Basel, Lausanne, Geneva,
and Zurich. The results were analysed and compiled by the office of HOVAT in
Basel. A working group with delegates from universities, the Swiss Academies
of Science and Medicine and the industry were involved in the coordination
of the survey and in the evaluation of the results. From the very beginning
support was provided by the Swiss Science Council (Schweizerischer Wissenschaftsrat/Conseil
Suisse de Science), which is greatly appreciated, particularly the thoughts
and comments of its president, Professor Verena Meyer.
We are very grateful to the coordinator, Dr. Christian Hodel (HOVAT), and his
collaborators, Dr. Timo Buetler, Mr. Markus Grieder, and Mr. Thomas Zürcher,
as well as Drs. Phaik Morgenthaler from the Institute of Pharmacology and Toxicology
in Lausanne for their dedicated and continuous help.
Prof. Urs Rüegg
University of Lausanne, 1015 Lausanne
President of the Swiss Society of Pharmacology and Toxicology (SSPT)
Dr. Beat Schmid
Novartis Consumer Health, 1260 Nyon
President of the Section of Toxicology of
the SSPT
Prof. Peter Meier-Abt
University of Zurich, 8091 Zurich
President of the Section of
Clinical Pharmacology of the SSPT
Conclusions
The present study has evaluated for the first time the state of toxicological
science and its associated institutions in Switzerland. Although the topic
is complex and the time frame of the study was limited, the information obtained
from the questionnaire in combination with four hearings enabled a representative
evaluation of the situation of toxicology in Switzerland.
Modern toxicology is multidisciplinary and its standard is highly dependent
on the quality of basic and applied research in molecular biosciences, technology,
experimental and social medicine and epidemiology. In many of these areas high
quality research and service groups are available in Switzerland. In spite
of this, several important issues were identified and need to be addressed.
After the year 2001 there will be no science-based institution devoted entirely
to toxicology in Switzerland. As research and education are intimately linked,
the Swiss academic institutions should take action to fill this gap. The somewhat
scattered and isolated highly qualified research groups in toxicology present
at various institutions could form the basis for a new structure of toxicology
in Switzerland. However, a minimum of one professorship in toxicology with
expansion of existing professorships dedicated to specific aspects of toxicology,
as part of their main curriculum, are required to maintain educational and
research needs. The academic institutions could provide the necessary basic
research to increase knowledge and develop methods for future needs, such as
mechanistic approaches for the assessment of new technologies and their inherent
risk for human and environmental health.
Many institutions, including governmental agencies, have indicated insufficient
in-house capacity and signalled a need for adequately trained staff. Services
provided by experts in different research institutes and a continuing education
programme could help to tackle this issue.
Future developments should be co-ordinated with industry who signalled a need
for experts in toxicology. Industrial toxicology requires an academic partner
and governmental agencies need experts who are familiar with international
organisations, guidelines and requirements, as well as with our geographical,
political, and cultural particularities.
There is a growing demand for toxicological expertise and risk assessment.
Only well-trained toxicologists with extensive practical and theoretical experience
are qualified to provide relevant answers and effective services.
There is growing public concern about health issues and rapidly expanding new
technologies. The obstacles for the public and politicians are that there is
no contact and information centre available where they can specify their requests
for help and guidance. Hence structures with competent experts will be increasingly
needed as providers of timely and relevant information and expertise. A major
task of the responsible individuals will include the co-ordination and transfer
of information between public, government, universities and industries.
Recommendations
The current analysis shows that there is significant competence in toxicology
and related areas in Switzerland. However there is an immediate need for action
due to the closure of the Institute of Toxicology in Schwerzenbach in 2001.
New structures led by academic institutions ought to be created.
We recommend the creation of a network of the centers and/or laboratories with
major interests in toxicology with a central reference institute, the Swiss
Center of Toxicology (called SWISSTOX).
The Center for Research on Xenobiotic and Environmental Risk at Zurich is a
local network using existing local competence within the two Zurich-based academic
institutions. Our recommendation is therefore an application of this structure
to participating academic institutions throughout Switzerland. and to include
the governmental agencies, and participating industries.
SWISSTOX should provide the following items or services:
Collaboration: encourage interactions and collaborative projects between
the Universities and the two Swiss Federal Institutes of Technology, the industry
and the governmental agencies with respect to research on xenobiotics.
Education: provide adequate integrated training programs for toxicologists,
at the undergraduate, doctoral and post-graduate level
Service function : providing toxicological data for the governmental
agencies and industry.
Public relations: communication of issues about toxicological matters
to the public.
Link across national borders: maintain and establish new links with
toxicological centers in European countries and with international societies.
Actions to be taken
As a first step, we recommend that a steering committee be formed. The Academies,
the SSPT, the Swiss Science Council and the Group for Science and Research
should be represented in this committee. The initial task of this committee
is to put forward a concrete plan of action to create SWISSTOX, if they are
in general agreement with the above recommendations.
The steering committee should elaborate a concise proposal regarding the structure,
the mission, the financing, and the time-frame of SWISSTOX.
At a later stage, an advisory panel of toxicological experts should be created
that will identify the strengths and weaknesses of the groups participating
in SWISSTOX. It also will be responsible for the definition of future strategies,
priorities and directions of toxicology oriented research, education and services
in Switzerland.
top |